Description and Brand Names
Información sobre medicamentos proporcionada por: IBM Micromedex
US Brand Name
- Praluent
Descriptions
Alirocumab injection is used together with a proper diet and other medicines (eg, ezetimibe, statin medicine) to treat patients with primary hyperlipidemia (including heterozygous familial hypercholesterolemia) or with homozygous familial hypercholesterolemia (HoFH), who need additional lowering of their bad cholesterol (LDL). It is also used to reduce the risk of heart attack, stroke, and unstable angina (chest pain) requiring hospitalization in adults with existing heart or blood vessel disease. This medicine is a PCSK9 (proprotein convertase subtilisin kexin type 9) inhibitor.
This medicine is available only with your doctor's prescription.
This product is available in the following dosage forms:
Portions of this document last updated: Nov. 01, 2022
Copyright © 2023 IBM Watson Health. Todos los derechos reservados. La información es para uso exclusivo del usuario final y no puede venderse, redistribuirse ni utilizarse de ninguna otra forma con fines comerciales.